Microbot Medical Inc. is a clinical-stage medical technology company dedicated to transforming minimally invasive surgery through innovative robotic solutions. Founded in 2011 and headquartered in Hingham, Massachusetts, the company specializes in micro-robotic technologies that navigate the natural and artificial lumens of the human body to perform complex medical procedures with precision and efficiency.

The company’s flagship product, the LIBERTY® Endovascular Robotic System, is the world’s first single-use, fully disposable robotic system for peripheral endovascular procedures. Designed to reduce the barriers of traditional robotic technologies, LIBERTY® makes advanced robotic-assisted surgery more accessible to hospitals and clinicians by eliminating the need for high-cost infrastructure. This allows healthcare providers to deliver safer, more precise, and efficient treatments to patients while expanding access to cutting-edge procedures.

Microbot Medical combines engineering innovation with a patient-centered approach, focusing on safety, reliability, and operational efficiency. By enabling clinicians to perform procedures with enhanced control and precision, the company is redefining the standard of care in endovascular therapy. With a commitment to research, development, and clinical excellence, Microbot Medical is shaping the future of robotic-assisted medical interventions and improving patient outcomes worldwide.